Permanent Capital Management LP bought a new position in shares of Danaher Co. (NYSE:DHR – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,661 shares of the conglomerate’s stock, valued at approximately $382,000.
Several other institutional investors also recently modified their holdings of DHR. Howard Capital Management Group LLC increased its holdings in shares of Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after buying an additional 48 shares in the last quarter. Concurrent Investment Advisors LLC increased its holdings in shares of Danaher by 2.9% in the third quarter. Concurrent Investment Advisors LLC now owns 3,787 shares of the conglomerate’s stock valued at $1,053,000 after buying an additional 108 shares in the last quarter. Advisor Resource Council bought a new position in shares of Danaher in the third quarter valued at $282,000. Walkner Condon Financial Advisors LLC acquired a new stake in Danaher during the 3rd quarter valued at $214,000. Finally, Washington Trust Bank raised its stake in Danaher by 8.4% during the 3rd quarter. Washington Trust Bank now owns 902 shares of the conglomerate’s stock valued at $251,000 after purchasing an additional 70 shares during the period. Institutional investors own 79.05% of the company’s stock.
Analysts Set New Price Targets
Several analysts have issued reports on the stock. Scotiabank assumed coverage on shares of Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price on the stock. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research note on Friday, December 13th. Jefferies Financial Group cut their target price on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Wells Fargo & Company cut their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Finally, Robert W. Baird cut their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $278.00.
Danaher Trading Down 1.1 %
Shares of NYSE:DHR opened at $212.35 on Friday. The stock has a market capitalization of $151.77 billion, a PE ratio of 40.22, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The firm has a fifty day moving average price of $222.51 and a 200 day moving average price of $243.02. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the firm earned $2.09 earnings per share. Analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.
Danaher Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.60%. Danaher’s payout ratio is currently 24.24%.
Insiders Place Their Bets
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 11.10% of the company’s stock.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Conference Calls and Individual Investors
- Is Myers Industries Poised for a Breakout?
- Using the MarketBeat Stock Split Calculator
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Airline Stocks – Top Airline Stocks to Buy Now
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.